As of November 2024, Hansa Biopharma AB (publ) has a market cap of $218.33M. This makes Hansa Biopharma AB (publ) the world's 16785th valuable company by market cap, according to our data. The market capitalization, also known as a stock market cap is a key financial indication. It represents the combined worth of all the outstanding shares of a publicly traded company multiplied by the current stock price. This figure is often used to see how much a company is worth. This figure is often used to see what is the company net worth.
Year | Market Cap | Change |
---|---|---|
2024 | $175.18M | 30.15% |
2023 | $134.60M | -46.77% |
2022 | $252.86M | -44.57% |
2021 | $456.19M | -63.06% |
2020 | $1.24B | 186.70% |
2019 | $430.76M | -69.71% |
2018 | $1.42B | 10.94% |
2017 | $1.28B | 114.16% |
2016 | $598.49M | 360.47% |
2015 | $129.97M | -6.86% |
2014 | $139.54M | 223.45% |
2013 | $43.14M | 127.85% |
2012 | $18.93M | -13.66% |
2011 | $21.93M | 12.09% |
2010 | $19.56M | -6.73% |
2009 | $20.98M | 27.69% |
2008 | $16.43M | -40.14% |
2007 | $27.45M | - |